HealthQuill COPD
The European Medicines Agency has approved Sanofi S.A.’s Dupixent (dupilumab) therapy as an add-on maintenance treatment for adults with uncontrolled chronic obstructive pulmonary disease, according to a company statement.
Drugs Health Pharma

EMA approves Sanofi’s treatment for obstructive pulmonary disease

The European Medicines Agency has approved Sanofi S.A.’s Dupixent (dupilumab) therapy as an add-on maintenance treatment for adults with uncontrolled chronic obstructive pulmonary.

Read More
Drugs Health Medical Pharma

Lab-made lung models facilitate faster drug testing and substitute animal subjects

Scientists in Australia have developed accurate lab models of human lungs that will help in therapeutic testings and do away with the need.

Read More
About 263 million children and young people worldwide are out of school, and achieving education for all by 2030 is "seriously off track," the UN stated. 
Climate Health Pharma

Pandemic, poverty keeping 260 million children out of school: UN

HQ Team April 12, 2023: About 263 million children and young people worldwide are out of school, and achieving education for all by.

Read More